Aarti PharmalabsNSE:AARTIPHARM +1.31%50 Days Inventory is 206.44 as of Mar. 2026, which is 1% above its 10-year median of 204.12. GuruFocus rates NSE:AARTIPHARM with a GF Score™ of 50/100 and a GF Value™ of ₹641.63 (Fairly Valued). The stock has 3 warning signs investors should review. Among 918 Drug Manufacturers companies, Aarti Pharmalabs ranks worse than 79.19% on this metric.
The historical rank and industry rank for Aarti Pharmalabs's Days Inventory or its related term are showing as below:
NSE:AARTIPHARM'
s Days Inventory Range Over the Past 10 Years
Min: 156.82 Med: 204.12 Max: 269.38
Current: 269.38
During the past 6 years, Aarti Pharmalabs's highest Days Inventory was 269.38. The lowest was 156.82. And the median was 204.12.
NSE:AARTIPHARM's Days Inventory is ranked worse than 79.19% of 918
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs NSE:AARTIPHARM: 269.38
Aarti Pharmalabs's Days Inventory
declined
from Mar. 2025 (206.49) to Mar. 2026 (206.44).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Aarti Pharmalabs's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.44.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Aarti Pharmalabs's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.10.
Aarti Pharmalabs (NSE:AARTIPHARM) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Aarti Pharmalabs's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Aarti Pharmalabs's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Aarti Pharmalabs Days Inventory Related Terms
Aarti Pharmalabs Days Inventory Historical Data
* Premium members only.
The historical data trend for Aarti Pharmalabs's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:AARTIPHARM vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Aarti Pharmalabs's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aarti Pharmalabs Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aarti Pharmalabs's Days Inventory distribution charts can be found below:
* The bar in red indicates where Aarti Pharmalabs's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aarti Pharmalabs (NSE:AARTIPHARM) has a Days Inventory of 206.44 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Aarti Pharmalabs and its competitors. This is near median its historical median of 204.12. Over the past decade, Aarti Pharmalabs' Days Inventory has ranged from 156.82 to 269.38. According to the industry distribution chart, Aarti Pharmalabs ranks #727 out of 918 companies in the Drug Manufacturers industry, placing it in the top 79.2%.
Is Aarti Pharmalabs' Days Inventory too high?
Aarti Pharmalabs' current Days Inventory of 206.44 is near median its 10-year median of 204.12. Over the past 10 years, this metric has ranged from a low of 156.82 to a high of 269.38. The Drug Manufacturers industry median Days Inventory is 164.43. Aarti Pharmalabs' value of 206.44 is 25.5% above this industry median. Based on the distribution chart, Aarti Pharmalabs ranks #727 out of 918 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Aarti Pharmalabs has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aarti Pharmalabs' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Aarti Pharmalabs ranks #727 out of 918 companies for Days Inventory. This places Aarti Pharmalabs in the lower half of its industry. The industry median Days Inventory is 164.43. Aarti Pharmalabs' value of 206.44 is 25.5% above this benchmark. Historically, Aarti Pharmalabs' own Days Inventory has ranged from 156.82 to 269.38 over the past decade. While the company's 10-year median is 204.12 vs. the industry median of 164.43, Aarti Pharmalabs has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aarti Pharmalabs's current Days Inventory of 206.44 is 25.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Aarti Pharmalabs and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aarti Pharmalabs's current Days Inventory is 206.44, which is near median its own 10-year median of 204.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aarti Pharmalabs stock overvalued right now?
Based on GuruFocus' analysis, Aarti Pharmalabs (NSE:AARTIPHARM) is currently considered Fairly Valued. The stock's GF Value™ is ₹641.63, compared to a current price of ₹706.35 — trading 10.1% above its estimated fair value. The current Days Inventory is 206.44, which is near median its 10-year median of 204.12 and 25.5% above the Drug Manufacturers industry median of 164.43. Aarti Pharmalabs' overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Aarti Pharmalabs (NSE:AARTIPHARM), the current Days Inventory is 206.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aarti Pharmalabs (NSE:AARTIPHARM) Overvalued in 2026?
Based on GuruFocus' analysis, Aarti Pharmalabs stock appears to be overvalued.
The current stock price of ₹706.35 is trading 10.1% above its estimated GF Value™ of ₹641.63.
GuruFocus considers Aarti Pharmalabs to be Fairly Valued.
Key valuation signals for NSE:AARTIPHARM:
Days Inventory: 206.44 (near median its 10-year median of 204.12)
GF Value™: ₹641.63 vs. price of ₹706.35 (10.1% above fair value)
Industry Position: 25.5% above the Drug Manufacturers median (#727 of 918)
No single metric tells the full story. See the NSE:AARTIPHARM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. The company manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, acids, and xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline in India. It also offers Contract Development and Manufacturing Services (CDMS) for drug substance (NCE, RSM, Intermediates) projects. Geographically, the company generates maximum revenue from its customers located outside India.
50GF Score
Get the complete analysis for NSE:AARTIPHARM
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AARTIPHARM has been successfully added to your 
